SMT Gets TGA Australia Approval for Supraflex Cruz
Sep 27, 2024
Mumbai (Maharashtra) [India], September 27: SMT (Sahajanand Medical Technologies), a global leader in innovative medical devices, proudly announces that its flagship drug-eluting stent (DES), Supraflex Cruz™, has received approval from the Therapeutic Goods Administration (TGA), Australia. The TGA is a part of the Australian Government Department of Health, and it's a regulatory authority for therapeutic goods in Australia.